Medical cannabis

By

01 Nov 2026

Medical Cannabis Tax Relief Leaves Adult-Use Operators Behind

Federal rescheduling has arrived, but only for part of the cannabis industry. In April, qualifying state-licensed medical cannabis moved from Schedule I to Schedule III of the Controlled Substances

• Section 280E

By

23 Jul 2026

Nebraska Public Opinion on Cannabis Shifts as Medical Market Matures

Nebraska's medical cannabis rollout is still finding its footing, but public sentiment is already moving. A new report from the University of Nebraska-Lincoln's Rural Drug Addiction Research Center

• Nebraska

By

01 Jul 2026

Ascend Wellness Files DEA Registration Apps Under Schedule III Medical Pathway

Ascend Wellness Holdings has filed applications with the U.S. Drug Enforcement Administration to register its state-licensed medical cannabis operations under the expedited pathway tied to

• Ascend Wellness Holdings

By

30 May 2026

Three State AGs Sue to Block Federal Cannabis Rescheduling, Putting Medical Patients in the Crossfire

The attorneys general of Nebraska, Indiana, and Louisiana filed suit last week to block the Trump administration's order rescheduling medical cannabis from Schedule I to Schedule III under the

• Cannabis Rescheduling

By

28 May 2026

UK Clinic Survey Finds 97% of Mental Health Patients Report Improvement on Medical Cannabis

Nearly all patients prescribed medical cannabis for anxiety, depression, or PTSD at UK clinics reported meaningful symptom improvement - that is the headline finding from a multi-clinic patient

• medical cannabis

By

27 May 2026

Cresco Labs Registers Medical Cannabis Operations With the DEA Under New Schedule III Rules

For the first time in the industry's history, a major multi-state operator has formally registered state-licensed cannabis facilities with the U.S. Drug Enforcement Administration - a direct

• Cresco Labs